ArticleEpilepsia2025
User-defined virtual sensors: A new solution to the problem of temporal plus epilepsy sources.
Article in Epilepsia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- White matter alterations in cluster headache identified using PSMD analysis.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveThe most common medically resistant epilepsy (MRE) involves the temporal lobe (TLE), and children designated as temporal plus epilepsy (TLE+) have a five-times increased risk of postoperative surgical failure. This retrospective, blinded, cross-sectional study aimed to correlate visual and computational analyses of magnetoencephalography (MEG) virtual sensor waveforms with surgical outcome and epilepsy classification (TLE and TLE+).
methodsPatients with MRE who underwent MEG and iEEG monitoring and had at least 1 year of postsurgical follow-up were included in this retrospective analysis. User-defined virtual sensor (UDvs) beamforming was completed with virtual sensors placed manually and symmetrically in the bilateral amygdalohippocampi, inferior/middle/superior temporal gyri, insula, suprasylvian operculum, orbitofrontal cortex, and temporoparieto-occipital junction. Additionally, MEG effective connectivity was computed and quantified using eigenvector centrality (EC) to identify hub regions. More conventional MEG methods (equivalent current dipole [ECD], standardized low-resolution brain electromagnetic tomography, synthetic aperture magnetometry beamformer), UDvs beamformer, and EC hubs were compared to iEEG.
resultsEighty patients (38 female, 42 male) with MRE (mean age = 11.3 ± 6.2 years, range = 1.0-31.5) were identified and included. Twenty-five patients (31.3%) were classified as TLE, whereas 55 (68.8%) were TLE+. When modeling the association between MEG method, iEEG, and postoperative surgical outcome (odds of a worse [International League Against Epilepsy (ILAE) class > 2] outcome), a significant result was seen only for UDvs beamformer (odds ratio [OR] = 1.22, 95% confidence interval [CI] = 1.01-1.48). Likewise, when the relationship between MEG method, iEEG, and classification (TLE and TLE+) was modeled, only UDvs beamformer had a significant association (OR = 1.47, 95% CI = 1.13-1.92). When modeling the association between EC hub location and resection/ablation to postoperative surgical outcome (odds of a good [ILAE 1-2] outcome), a significant association was seen (OR = 1.22, 95% CI = 1.05-1.43). SIGNIFICANCE: This study demonstrates a concordance between UDvs beamforming and iEEG that is related to both postsurgical seizure outcome and presurgical classification of epilepsy (TLE and TLE+). UDvs beamforming could be a complementary approach to the well-established ECD, improving invasive electrode and surgical resection planning for patients undergoing epilepsy surgery evaluations and treatments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.